IPPRA / Grant Monitor

2026-11-05
← Board

NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

RFA-EB-28-004 · National Institutes of Health

biomedical clinical public health Health

Closes
2030-12-01 · 1487 d
Award ceiling
—
Award floor
—
Program funding
$6,000,000
Expected awards
4
Cost sharing
No
Posted
2026-10-23
Instrument
Grant
Characterization · gpt-5.4-mini · 2026-10-24

NIH funds translation and development of next-generation diagnostic and therapeutic devices for disorders within the BRAIN and HEAL missions, up to readiness for first-in-human clinical trials, for eligible applicants including universities.

Funds
applied research
University
direct
social behavioral
minor
physical sciences
minor
engineering
central
life biomedical
central
computational data
minor

⚑ Clinical trials not allowed · Supports device translation and human-use readiness, not first-in-human enrollment · Relevant to NIH BRAIN and HEAL initiative missions

12 / 100 IPPRA team judgment

This is a biomedical device-development program aimed at translational neuroscience/addiction technologies and readiness for first-in-human trials, which is far outside IPPRA’s social-behavioral/public opinion, policy, and hazard-communication lines. The team might engage only peripherally on public acceptance or implementation questions, but it is not plausibly a PI-level fit for any member.

JUDGED AGAINST THE ROSTER'S PUBLICATION DOSSIER · GPT-5.4-MINI · 2026-10-24

Unit fits — one characterization, each unit's own rules

Physical Sciences & Engineering (demo) 80 strong technical depth: central; funds applied research
IPPRA 58 good peripheral portfolio topic: public_health; social/behavioral work is minor; funds applied research; biomedical core — IPPRA health lane is communication/crisis/policy (capped)
Tom Love Innovation Hub 45 partial funds applied research; prototyping/demonstration stage; deep-tech content

Description

This Notice of Funding Opportunity (NOFO) is to encourage applications from investigators to advance the development and translation of next-generation technologies to prevent, monitor, diagnose, and treat disorders within the missions of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) and The Helping to End Addiction Long-term (HEAL) Initiatives. Awarded activities will facilitate the translation of new devices up to the stage of readiness for first in human (FIH) clinical trials by overcoming key challenges identified during preliminary proof-of-concept studies. The scope of the program includes technology development and optimization, and studies to prepare for approvals for human use.

Eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Apply

View on Grants.gov → CONTACT: National Institutes of Health <NIBIB_Devices@NIH.gov>

Proposal brief SEE AN EXAMPLE →

A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · National Institutes of Health conventions SEE AN NIH EXAMPLE →

Funder-faithful document skeletons — National Institutes of Health's document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING